Cargando…
Therapeutic Vaccines for Tuberculosis: An Overview
Tuberculosis (TB), caused by Mycobacterium tuberculosis is the world’s deadliest bacterial infection, resulting in more than 1.4 million deaths annually. The emergence of drug-resistance to first-line antibiotic therapy poses a threat to successful treatment, and novel therapeutic options are requir...
Autores principales: | Bouzeyen, Rania, Javid, Babak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263712/ https://www.ncbi.nlm.nih.gov/pubmed/35812462 http://dx.doi.org/10.3389/fimmu.2022.878471 |
Ejemplares similares
-
Co-Administration of Anticancer Candidate MK-2206 Enhances the Efficacy of BCG Vaccine Against Mycobacterium tuberculosis in Mice and Guinea Pigs
por: Bouzeyen, Rania, et al.
Publicado: (2021) -
FOXO3 Transcription Factor Regulates IL-10 Expression in Mycobacteria-Infected Macrophages, Tuning Their Polarization and the Subsequent Adaptive Immune Response
por: Bouzeyen, Rania, et al.
Publicado: (2019) -
Research Advances for Virus-vectored Tuberculosis Vaccines and Latest Findings on Tuberculosis Vaccine Development
por: Hu, Zhidong, et al.
Publicado: (2022) -
Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics
por: Enriquez, Ana B., et al.
Publicado: (2021) -
Peptide-Based Vaccines for Tuberculosis
por: Gong, Wenping, et al.
Publicado: (2022)